The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

New CRC therapies? Anti-PDL1 immunotherapy or CAR-T cell therapies?

gergery
gergery CSN Member Posts: 1
edited May 2017 in Colorectal Cancer #1

Newbie here. My friend was just diagnosed with Stage IV CRC, spread to abdomen, lymph nodes, liver, couple of spots on the lungs and one spot on the bone.  Adenocarcinoma NRAS Q61R mutation.  Female, age 47. We are trying to learn about novel therapies to treat this. 

Does anyone have experience with:

1. Anti-PDL1 immunotherapy. Seems to target NRAS Q61R for Melanoma (skin cancer). Might it work for NRAS Q61R colorectal cancer too?

2. CAR-T cell therapies. Work for blood cancer. Might it work for CRC too?

3. An Anti PD L1 approach

4. If we do find an experimental trial, any advice on better ways to get into it?

 

Any help appreciated, on the above or any other advice. As you can imagine, this will be difficult, but we will fight and beat this.
Like Care

Discussion Boards